Newly diagnosed idiopathic thrombocytopenic purpura in childhood:: an observational study

被引:185
作者
Kühne, T
Imbach, P
Bolton-Maggs, PHB
Berchtold, W
Blanchette, V
Buchanan, GR
机构
[1] Univ Childrens Hosp, Div Oncol, CH-4005 Basel, Switzerland
[2] Univ Childrens Hosp, Div Haematol, CH-4005 Basel, Switzerland
[3] Royal Liverpool Childrens Hosp, Liverpool L7 7DG, Merseyside, England
[4] Univ Appl Sci Aargau, Brugg, Switzerland
[5] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[6] Univ Texas, SW Med Ctr, Dallas, TX USA
关键词
D O I
10.1016/S0140-6736(01)07219-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diagnosis and management of idiopathic thrombocytopenic purpura (ITP) have been based primarily on expert opinion and practice guidelines rather than on evidence. We have used a registry to prospectively survey the presenting features and the diagnostic evaluation and management practices used for children with ITP worldwide. Methods We used the Intercontinental Childhood ITP Registry which had been widely advertised. 209 physicians from 136 institutions in 38 countries participated by submitting data for each of their newly diagnosed patients. Data from 2031 children with TP was registered between June, 1997, and May, 2000, and we analysed 6-month follow-up data from 1496 children. Findings There was a peak in occurrence of childhood ITP during spring and a nadir in the autumn. Mean initial platelet count was 15.4x10(9)/L (SD 19.7). 1447 (73%) of 1976 children were admitted to hospital. Initial management consisted of no drug treatment in 612 (31%), intravenous immunoglobulin in 576 (29%), corticosteroids in 651 (33%), or both in 137 (7%) patients. Intracranial haemorrhage was reported in two patients. Interpretation The variable approaches to management of childhood ITP demonstrate the need for prospective clinical trials, which should be feasible within such a study group.
引用
收藏
页码:2122 / 2125
页数:4
相关论文
共 24 条
[1]   17 YEARS OF EXPERIENCE WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD - IS THERAPY ALWAYS BETTER [J].
ARONIS, S ;
PLATOKOUKI, H ;
MITSIKA, A ;
HAIDAS, S ;
CONSTANTOPOULOS, A .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (05) :487-498
[2]   A PROSPECTIVE, RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS IMMUNE GLOBULIN G THERAPY, ORAL PREDNISONE THERAPY, AND NO THERAPY IN CHILDHOOD ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].
BLANCHETTE, VS ;
LUKE, B ;
ANDREW, M ;
SOMMERVILLENIELSEN, S ;
BARNARD, D ;
DEVEBER, B ;
GENT, M .
JOURNAL OF PEDIATRICS, 1993, 123 (06) :989-995
[3]  
BLANCHETTE VS, 1985, J PEDIATR, V108, P326
[4]   Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines [J].
BoltonMaggs, PHB ;
Moon, I .
LANCET, 1997, 350 (9078) :620-623
[5]  
Buchanan GR, 1997, BLOOD, V89, P1464, DOI 10.1182/blood.V89.4.1464
[6]  
BUCHANAN GR, 1984, AM J PEDIAT HEMATOL, V6, P355
[7]  
Calpin C, 1998, ARCH PEDIAT ADOL MED, V152, P345
[8]   The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment [J].
Dickerhoff, R ;
von Ruecker, A .
JOURNAL OF PEDIATRICS, 2000, 137 (05) :629-632
[9]  
DUBANSKY AS, 1989, PEDIATRICS, V84, P1068
[10]   GUIDELINES FOR MANAGEMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA [J].
EDEN, OB ;
LILLEYMAN, JS .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (08) :1056-1058